HER2+ Breast Cancer: Anthracycline Considerations
Experts discuss anthracycline use in HER2+ breast cancer and provide insights into how patient scenarios, heterogeneity, and neuropathy concerns shape considerations in diverse clinical situations.
Stay updated with breaking news from Clinical Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts discuss anthracycline use in HER2+ breast cancer and provide insights into how patient scenarios, heterogeneity, and neuropathy concerns shape considerations in diverse clinical situations.
You've heard of the Golden Globes, the Emmys and of course the Oscars. Last month Norfolk General Hospital and...
Marty Nichols, now Associate Director at NSW Ambulance, reflects on his 23-year career in paramedicine and the challenges he faced, including the COVID-19 pandemic.
Experts discuss evidence-based strategies in neoadjuvant therapy for HER2+ breast cancer and provide insights on surgery-first considerations, disease size impact, and personalized pre-operative regimens.